Streetbeat News

Analyst Ratings

SMCI

Rosenblatt analyst Hans Mosesmann initiates coverage on Super Micro Computer (NASDAQ:SMCI) with a Buy rating and a price target of $300.

Portfolio Pulse from richadhand@benzinga.com

June 07, 2023 | 8:08 am

NVCR

Wedbush analyst David Nierengarten upgrades NovoCure (NASDAQ:NVCR) from Underperform to Neutral and lowers the price target from $53 to $46.

Portfolio Pulse from richadhand@benzinga.com

June 07, 2023 | 8:05 am

PINE

JonesTrading analyst Jason Stewart reiterates a Buy rating on Alpine Income Prop Trust (NYSE:PINE) and maintains a $24 price target.

Portfolio Pulse from richadhand@benzinga.com

June 07, 2023 | 8:01 am

CIEN

Raymond James analyst Simon Leopold maintains a Strong Buy rating on Ciena (NYSE:CIEN) but lowers the price target from $70 to $63.

Portfolio Pulse from richadhand@benzinga.com

June 07, 2023 | 7:59 am

ABNB

Needham analyst Bernie McTernan reiterated a Buy rating on Airbnb (NASDAQ:ABNB) and maintained a $150 price target.

Portfolio Pulse from richadhand@benzinga.com

June 07, 2023 | 7:58 am

GIII

Keybanc analyst Noah Zatzkin maintains an Overweight rating on G-III Apparel Group (NASDAQ:GIII) and raises the price target from $18 to $23.

Portfolio Pulse from richadhand@benzinga.com

June 07, 2023 | 7:57 am

GLD

IAU

DoubleLine Capital CEO Jeffrey Gundlach predicts the US is on the verge of a recession, citing indicators such as ISM new orders and the purchasing managers' index. This contrasts with Goldman Sachs' recent reduction of the US recession probability from 35% to 25%. Gundlach's preferred portfolio mix consists of 30% stocks, 60% bonds, and 10% real assets, including gold.

Portfolio Pulse from Bhavik Nair

June 07, 2023 | 3:22 am

DTE

In the last quarter, DTE Energy (NYSE:DTE) received 4 bullish, 3 somewhat bullish, and 2 indifferent analyst ratings. The company has an average 12-month price target of $123.11, representing a 2.46% decrease from the previous average of $126.22.

Portfolio Pulse from Benzinga Insights

June 06, 2023 | 9:02 pm

IMGN

Immunogen (NASDAQ: IMGN) has received positive analyst ratings in the last quarter, with an average 12-month price target of $17.0, a high of $19.00, and a low of $15.00. The average price target has increased by 41.67% over the past month.

Portfolio Pulse from Benzinga Insights

June 06, 2023 | 9:02 pm

TSLA

Over the past 3 months, 27 analysts have published their opinion on Tesla (NASDAQ:TSLA) stock, with an average 12-month price target of $208.59, a 2.29% decrease from the previous average price target of $213.48.

Portfolio Pulse from Benzinga Insights

June 06, 2023 | 9:01 pm